Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nanologica AB (DE:4YD)
FRANKFURT:4YD
Holding DE:4YD?
Track your performance easily
4YD Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.18 - €0.95
Previous Close€0.18
Volume0.00
Average Volume (3M)N/A
Market Cap
€9.06M
Enterprise Value€3.26M
Total Cash (Recent Filing)kr70.32M
Total Debt (Recent Filing)kr4.69M
Price to Earnings (P/E)―
Beta-0.47
Next Earnings
Oct 25, 2024EPS Estimate
-€0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)164.12
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nanologica AB News
PremiumPre-Earnings
Is 4YD a Buy, Before Earnings?
4YD FAQ
What was Nanologica AB’s price range in the past 12 months?
Nanologica AB lowest stock price was €0.18 and its highest was €0.94 in the past 12 months.
What is Nanologica AB’s market cap?
Currently, no data Available
When is Nanologica AB’s upcoming earnings report date?
Nanologica AB’s upcoming earnings report date is Oct 25, 2024 which is in 34 days.
How were Nanologica AB’s earnings last quarter?
Nanologica AB released its earnings results on Jul 05, 2024. The company reported -€0.022 earnings per share for the quarter, beating the consensus estimate of -€0.026 by €0.004.
Is Nanologica AB overvalued?
According to Wall Street analysts Nanologica AB’s price is currently Overvalued.
Does Nanologica AB pay dividends?
Nanologica AB does not currently pay dividends.
What is Nanologica AB’s EPS estimate?
Nanologica AB’s EPS estimate is -€0.02.
How many shares outstanding does Nanologica AB have?
Nanologica AB has 44,178,620 shares outstanding.
What happened to Nanologica AB’s price movement after its last earnings report?
Nanologica AB reported an EPS of -€0.022 in its last earnings report, beating expectations of -€0.026. Following the earnings report the stock price went down -4.082%.
Which hedge fund is a major shareholder of Nanologica AB?
Currently, no hedge funds are holding shares in DE:4YD
---
Nanologica AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Nanologica AB
Nanologica AB develops and manufactures nanoporous silica particles for life science applications. It focuses on two areas: Drug Development and Chromatography. The company's drug delivery platforms are NLAB Spiro and NLAB Silica, which aim to produce better medicines for the benefit of patients. Its geographical segments are Sweden, China, the United States, and the Rest of the world.
---
Technical Analysis
---